Our study confirmed that CD133+ SFCs sorted by MACS LS column from the SMMC-7721 human liver cancer cell line showed an enhanced capacity of EMT and had greater tumorigenicity than the parental cells, which indicated that CD133+ SFCs enriched LCSCs. This evidence concerns the gene PROM1 and liver cancer.